Medication info
Terigle Tablet 20 mg (Teneligliptin Hydrobromide Hydrate)

Terigle Tablet 20 mg (Teneligliptin Hydrobromide Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Ditosylate Dihydrate›37.84mg / 1 tablet
Manufacturer / importer
Shinpoong Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets / bottle
Approval status
Active

MFDS item code 202201759 · Approved 2022.04.27 · Insurance code 648507990

Summary

Main use
Improves glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine, whether used alone or in combination therapy, is 20 mg once daily. It may be taken with or without food. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. No dosage adjustment is necessary in patients with renal impairment. No dosage adjustment is necessary in patients with mild to moderate hepatic impairment.

Ingredients

Manufacturer
Shinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improves glycemic control in type 2 diabetes mellitus

  • Blood sugar control issues in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. It aids in blood glucose management whether used alone or in combination with other medications. This helps to stabilize blood glucose levels for patients with diabetes.

How to take

Adult dose

The recommended dose of this medicine, whether used alone or in combination therapy, is 20 mg once daily. It may be taken with or without food. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. No dosage adjustment is necessary in patients with renal impairment. No dosage adjustment is necessary in patients with mild to moderate hepatic impairment.

Precautions

This medication should not be used by individuals with allergic reactions to the active ingredient or other components. Insulin treatment is required for patients with diabetic ketoacidosis, comatose states, or type 1 diabetes, making this medication inappropriate. It is advisable not to use this medication for patients with severe infections, pre- or post-surgery, or severe injuries as they may also require insulin treatment. Caution should be exercised when administering this medication to patients with severe liver dysfunction, as there is limited experience with its use in these patients. For patients with mild to moderate heart failure, it should be used cautiously while it is not recommended for those with severe heart failure. Caution is needed for patients taking sulfonylureas or insulin due to the risk of hypoglycemia. Patients with high risk of hypoglycemia such as those with pituitary or adrenal insufficiency, nutritional deficiencies, irregular meals, intense exercise, or excessive alcohol consumption should also be used with caution. Caution is warranted for those with a history of abdominal surgery or bowel obstruction due to the risk of gastrointestinal side effects. Patients with cardiac arrhythmias or a tendency to prolonged QT intervals should avoid this medication due to the risk of side effects during use. Symptoms of acute pancreatitis may occur, so patients experiencing severe abdominal pain or vomiting should promptly inform medical personnel. Various side effects including hypoglycemia, constipation, liver function abnormalities, interstitial lung disease, skin rash, and acute pancreatitis may occur, so patients should consult a physician immediately if any abnormal symptoms arise. Particularly, when taken with other diabetes medications, the risk of hypoglycemia may increase, so careful monitoring of blood glucose status is essential. If symptoms of hypoglycemia occur, appropriate measures such as consuming sugar-containing food should be taken. This medication is not recommended for use during pregnancy and should be used cautiously during breastfeeding. Safety in pediatrics has not been established, hence it is advisable not to use in children. Elderly patients should be monitored closely for their physical condition, as body functions may be impaired. In the event of overdose, general treatment along with supportive measures tailored to the patient's condition is required. This medication should be kept out of reach of children, and transferring it to other containers should be avoided. Additionally, it may interact with other blood glucose-lowering medications; thus, patients should inform their physician about any other medications they are taking. If severe joint pain or blisters on the skin occur during the course of therapy, immediate consultation with medical personnel is needed, and discontinuation of the medication may be required.

Side effects

  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • bullous pemphigoid
  • acute pancreatitis
  • dizziness
  • abdominal distension
  • abdominal discomfort
Show 57 more
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colonic polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • amylase elevation
  • lipase elevation
  • AST (GOT) elevation
  • ALT (GPT) elevation
  • GGT elevation
  • ALP elevation
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • CK (CPK) elevation
  • serum potassium level elevation
  • fatigue
  • allergic rhinitis
  • serum uric acid elevation
  • peripheral edema
  • nasopharyngitis
  • foot fractures
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • dizziness
  • upper respiratory infection
  • headache
  • dyspepsia
  • chronic gastritis
  • irritable bowel syndrome
  • viral upper respiratory infection
  • fatigue
  • tremors
  • weakness
  • hunger
  • facial edema
  • nausea
  • cold sweat
  • diabetic retinopathy
  • vision impairment
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight container, preferably at room temperature between 1 to 30 degrees Celsius. This helps maintain the effectiveness of the medication for a longer duration.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets / bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.